WAQ75601 (e) Wedi’i gyflwyno ar 10/01/2018

Pa gynlluniau sydd gan Ysgrifennydd y Cabinet i ymestyn argaeledd Savitex i bobl sy'n dioddef o sglerosis ymledol yng Nghymru?

Wedi'i ateb gan Prif Weinidog | Wedi'i ateb ar 18/01/2018

Sativex is routinely available as an option to treat multiple sclerosis sufferers in Wales who meet the clinical criteria specified by the All-Wales Medicines Strategy Group and who are likely to benefit from it. This is for individual clinicians to determine.